Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2025)
Historic Change in Intangibles for Biomarin Pharmaceutical (BMRN) over the last 9 years, with Q3 2025 value amounting to $5.3 million.
- Biomarin Pharmaceutical's Change in Intangibles rose 9546.63% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 6664.91%. This contributed to the annual value of $12.0 million for FY2024, which is 983.52% up from last year.
- Per Biomarin Pharmaceutical's latest filing, its Change in Intangibles stood at $5.3 million for Q3 2025, which was up 9546.63% from $266000.0 recorded in Q2 2025.
- Over the past 5 years, Biomarin Pharmaceutical's Change in Intangibles peaked at $15.6 million during Q4 2021, and registered a low of $266000.0 during Q2 2025.
- For the 5-year period, Biomarin Pharmaceutical's Change in Intangibles averaged around $3.5 million, with its median value being $1.8 million (2022).
- As far as peak fluctuations go, Biomarin Pharmaceutical's Change in Intangibles tumbled by 9570.45% in 2022, and later surged by 248064.52% in 2024.
- Over the past 5 years, Biomarin Pharmaceutical's Change in Intangibles (Quarter) stood at $15.6 million in 2021, then crashed by 95.7% to $671000.0 in 2022, then skyrocketed by 1059.31% to $7.8 million in 2023, then plummeted by 90.11% to $769000.0 in 2024, then skyrocketed by 589.6% to $5.3 million in 2025.
- Its Change in Intangibles stands at $5.3 million for Q3 2025, versus $266000.0 for Q2 2025 and $769000.0 for Q4 2024.